Website stats for Omeros - omeros.com
Innovative Cutting-edge Science Premier Groundbreaking Innovative;Cutting-edge;Premier;Groundbreaking;World-class Ultra-orphan to large-market Deep and diverse Pipeline First-in-class Data-driven Ultra-orphan to large-market;Deep and diverse;First-in-class;Data-driven;Unmet needs Creative Collaborativ...
omeros.com was registered 2 decades 7 years ago. It has a alexa rank of #2,175,231 in the world. It is a domain having .com extension. It is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently, omeros.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 403 |
| Daily Pageviews: | 806 |
Estimated Valuation
| Income Per Day: | $ 2.00 |
| Estimated Worth: | $ 480.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 2,175,231 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
44.199.127.36
Hosted Country:
US
Location Latitude:
39.0395Location Longitude:
-77.4918Traffic Classification
| Total Traffic: | Not Applicable |
| Direct Traffic: | Not Applicable |
| Referral Traffic: | Not Applicable |
| Search Traffic: | Not Applicable |
| Social Traffic: | Not Applicable |
| Mail Traffic: | Not Applicable |
| Display Traffic: | Not Applicable |
Search Engine Results For omeros.com
MASP-2 Therapy for Macular Degeneration | SBIR.gov
OMEROS CORPORATION. 1420 5TH AVE SUITE 2600. SEATTLE, WA 98101. United States. DUNS: 033364923 ... Email: [email protected]. Research Institution.
Omeros - Crunchbase Company Profile & Funding
Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein ...
Omeros Corporation - Home - Facebook
201 Elliott Ave W, Seattle, WA 98119. Get Directions. 57 people checked in here. http://www.omeros.com/. (206) 676-5000. Biotechnology Company. Open now.
Working at Omeros - Glassdoor
See what employees say it's like to work at Omeros. Salaries, reviews, and more - all posted by employees working at Omeros.
Omeros Corporation Company Information | Drugs.com
Omeros Corporation manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names ...
Omeros Corporation - Cruelty Free Investing
Omeros Corporation is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials. Supporting Evidence:.
Omeros Corp (@OmerosCorp) / Twitter
Omeros will be at the European Hematology Association Congress in Vienna, June 9-12. Visit our booth #780 to learn more about the lectin pathway and ...
Omeros Corp - Reuters
Omeros Corporation is a biopharmaceutical company. ... Its lead lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a ...
Omeros (NasdaqGM:OMER) - Share price, News & Analysis
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, ...
Omeros Corporation to Announce First Quarter Financial Results on ...
May 4, 2022 ... SEATTLE, May 04, 2022--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results ...
Omeros – Next-generation Therapeutics Transforming Patient Care
Omeros is breaking the mold in the pharmaceutical industry through novel discovery, strategic translational research, and vigorous clinical programs.
Omeros Corp - Company Profile and News - Bloomberg Markets
Omeros Corporation operates as a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, ...
Omeros Corp. - CMOCRO
Omeros is an innovative biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for ...
Working At Omeros: Employee Reviews and Culture - Zippia
Omeros Overview. Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule ...
Omeros Company Profile - Office Locations, Competitors, Revenue ...
Omeros has 277 employees at their 1 location. See insights on Omeros including office locations, competitors, revenue, financials, executives, ...
OMER - Omeros Corp Company Profile - CNNMoney.com
The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan ...
Omeros Corporation Company Profile - HireLifeScience.com
Jobs 1 - 10 of 58 ... Clinical Trial Associate The Clinical Trials Associate (CTA) is responsible for performing in-house clinical trial administrative duties in ...
Omeros Corp (OMER) - WhaleWisdom.com
View 13F filing holders of Omeros Corp. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers.
Omeros Corporation Common Stock (OMER) - Nasdaq
Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics ...
OMIDRIA® (phenylephrine & ketorolac) | Official Patient Site
OMEROS®, the OMEROS logo®, OMIDRIA®, the OMIDRIA logo®, and OMIDRIAssure® are registered trademarks of Omeros Corporation. © Omeros Corporation 2021, all rights ...
Omeros (company) - Wikipedia
Omeros Corporation, also known as Omeros, is an American biopharmaceutical company based in Seattle, Washington. It was founded in 1994 by Gregory A.
Omeros Corporation Email Format - RocketReach
Omeros Corporation uses 2 email formats: 1. first_initial [email protected] (99.0%). Enter a name to find & verify an email >>>
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 4 |
| H3 Headings: | 1 | H4 Headings: | 1 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 6 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Contact Us | 4 | 0.905 % | No |
| About Omeros | 4 | 0.905 % | No |
| and diverse | 3 | 0.679 % | No |
| Us Share | 3 | 0.679 % | No |
| Investors News | 3 | 0.679 % | No |
| News Careers | 3 | 0.679 % | No |
| Careers Contact | 3 | 0.679 % | No |
| to Patients | 2 | 0.452 % | No |
| we are | 2 | 0.452 % | No |
| All rights | 2 | 0.452 % | No |
| rights reserved | 2 | 0.452 % | No |
| Commitment to | 2 | 0.452 % | No |
| Information Request | 2 | 0.452 % | No |
| GPR161 Medical | 2 | 0.452 % | No |
| the way | 2 | 0.452 % | No |
| Request Patients | 2 | 0.452 % | No |
| Patients Commitment | 2 | 0.452 % | No |
| use of | 2 | 0.452 % | No |
| to the | 2 | 0.452 % | No |
| pipeline of | 2 | 0.452 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Careers Contact Us Share | 3 | 0.679 % | No |
| Investors News Careers Contact | 3 | 0.679 % | No |
| News Careers Contact Us | 3 | 0.679 % | No |
| OMS527 OMS906 MASP2 MASP3 | 2 | 0.452 % | No |
| OMS906 MASP2 MASP3 MASP23 | 2 | 0.452 % | No |
| MASP2 MASP3 MASP23 GPR174 | 2 | 0.452 % | No |
| OMS405 OMS527 OMS906 MASP2 | 2 | 0.452 % | No |
| Narsoplimab OMS721 OMS405 OMS527 | 2 | 0.452 % | No |
| Overview Narsoplimab OMS721 OMS405 | 2 | 0.452 % | No |
| MASP23 GPR174 GPR161 Medical | 2 | 0.452 % | No |
| OMS721 OMS405 OMS527 OMS906 | 2 | 0.452 % | No |
| GPR161 Medical Information Request | 2 | 0.452 % | No |
| Patients Commitment to Patients | 2 | 0.452 % | No |
| science lead the way | 2 | 0.452 % | No |
| Request Patients Commitment to | 2 | 0.452 % | No |
| Information Request Patients Commitment | 2 | 0.452 % | No |
| Pipeline Overview Narsoplimab OMS721 | 2 | 0.452 % | No |
| Medical Information Request Patients | 2 | 0.452 % | No |
| GPR174 GPR161 Medical Information | 2 | 0.452 % | No |
| MASP3 MASP23 GPR174 GPR161 | 2 | 0.452 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Fri, 17 Jun 2022 11:55:21 GMT
Server: Apache
Link:
Vary: Accept-Encoding
Content-Encoding: gzip
X-Content-Type-Options: nosniff
X-Frame-Options: sameorigin
Cache-Control: no-store
X-Xss-Protection: 1; mode=block
Content-Length: 12711
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 1997-01-17 2 decades 7 years 5 months ago |
| Last Modified: | 2022-03-03 2 years 4 months 15 hours ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.no-ip.com | |
194.62.181.53 |  United Kingdom |
| ns2.no-ip.com | |
194.62.180.53 | United Kingdom |
| ns3.no-ip.com | |
204.16.255.53 | United States |
| ns4.no-ip.com | |
204.16.254.53 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| omeros.com | A | 283 |
IP: 44.199.127.36 |
| omeros.com | NS | 86400 |
Target: ns4.no-ip.com |
| omeros.com | NS | 86400 |
Target: ns5.no-ip.com |
| omeros.com | NS | 86400 |
Target: ns1.no-ip.com |
| omeros.com | NS | 86400 |
Target: ns2.no-ip.com |
| omeros.com | NS | 86400 |
Target: ns3.no-ip.com |
| omeros.com | SOA | 86400 |
MNAME: ns2.no-ip.com RNAME: hostmaster.no-ip.com Serial: 2016101452 Refresh: 10800 Retry: 1800 Expire: 604800 |
| omeros.com | MX | 1800 |
Priority: 10 Target: us-smtp-inbound-1.mimecast.com |
| omeros.com | MX | 1800 |
Priority: 10 Target: us-smtp-inbound-2.mimecast.com |
| omeros.com | TXT | 300 |
TXT: adobe-idp-site-verification=fdce3ba1ecd3 704cc4d261e00bf061f38e711d4f33b18fa63fb2 056e76fa3fdc |
| omeros.com | TXT | 300 |
TXT: 76df4b93bd58412fb214cb3b1f2e65ae |
| omeros.com | TXT | 300 |
TXT: docusign=e8592a62-b686-4aa7-bfb1-87b0fda c2c5c |
| omeros.com | TXT | 300 |
TXT: google-site-verification=clVOn_ipnGGqxMP En2IutcodMo3Ae1W0UlUlIOtYCeA |
| omeros.com | TXT | 300 |
TXT: v=verifydomain MS=2935144 |
| omeros.com | TXT | 300 |
TXT: apple-domain-verification=7r3BevRokJCpVg LF |
| omeros.com | TXT | 300 |
TXT: docusign=7245a100-fce4-4433-ac70-bb8a117 8286a |
| omeros.com | TXT | 300 |
TXT: atlassian-domain-verification=6sQ175cIlL sSPy69Ne6JWzdEl+XMr8PlOQ6Ku9V++5VTtOXY9e ZWU6h8/RHoysce |
| omeros.com | TXT | 300 |
TXT: y4bj0jmc731wgt9gwqxzwdwpg4g82xg2 |
| omeros.com | TXT | 300 |
TXT: v=spf1 ip4:209.170.239.199 ip4:147.154.97.253 ip4:12.19.100.11 ip4:66.18.116.249 ip4:129.152.47.16/28 include:us._netblocks.mimecast.com include:_spf.mailgun.org include:_spf.salesforce.com ~all |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
2461378_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2022-03-02T18:53:43Z
Creation Date:
1997-01-17T05:00:00Z
Registry Expiry Date:
2023-03-01T11:59:59Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.NO-IP.COM
Name Server: NS2.NO-IP.COM
Name Server:
NS3.NO-IP.COM
Name Server: NS4.NO-IP.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2022-06-17T11:55:16Z
Similarly Ranked Websites
SOLARTEC - Energia Solar
Empresa líder en la fabricación e instalación de paneles y sistemas eléctricos solares en Argentina. Conocé nuestra amplia línea de soluciones y productos.
2,175,239 
$ 480.00
Ты Купи интернет-магазин кожгалантереи в Киеве. Купить аксессуары и...
2,175,261 $ 480.00
Investasi Berdampak untuk Peternak - Bantuternak
Bantuternak adalah Aplikasi investasi digital yang berfokus memberdayakan peternak melalui penyaluran modal dan pendampingan peternak.
2,175,271 $ 480.00
Dragonara Partners ~ Online Casino Affiliate Program |
Dragonara Partners is the affiliate network for Dragonara Online Casino. To Celebrate our 50 years in operation, We offer our Dragonara Partners up to 50% in commission!
2,175,276 $ 480.00
OpenSistemas
Descubre la consultora tecnológica más disruptiva que aprovecha la tecnología digital. Servicios y soluciones tecnológicas basadas en datos y en la nube.
2,175,281 $ 480.00